Trial intelligence / Profile preview

CTC vs Radiography for Recurrence in Colorectal Cancer

NCT04917289Phase 3Not yet recruiting

Sponsor
Fudan University
Start
Jun 2021
Primary completion
Dec 2023
01

Overview

Phase 3, randomised, open-label trial in colorectal cancer (CRC) (2 arms), sponsored by Fudan University. Primary endpoint: Overall Survival at 3 years. Planned start Jun 2021; status: not yet recruiting.

02

Conditions

colorectal cancer (CRC)

Beyond the preview

Go deeper on NCT04917289.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04917289.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call